476 related articles for article (PubMed ID: 30977109)
1. Association of Hyponatraemia and Antidepressant Drugs: A Pharmacovigilance-Pharmacodynamic Assessment Through an Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Mazhar F; Pozzi M; Gentili M; Scatigna M; Clementi E; Radice S; Carnovale C
CNS Drugs; 2019 Jun; 33(6):581-592. PubMed ID: 30977109
[TBL] [Abstract][Full Text] [Related]
2. Other Antidepressants.
Schwasinger-Schmidt TE; Macaluso M
Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
[TBL] [Abstract][Full Text] [Related]
3. Role of Serotonin Transporter in Antidepressant-Induced Diabetes Mellitus: A Pharmacoepidemiological-Pharmacodynamic Study in VigiBase
Nguyen TTH; Roussin A; Rousseau V; Montastruc JL; Montastruc F
Drug Saf; 2018 Nov; 41(11):1087-1096. PubMed ID: 29956218
[TBL] [Abstract][Full Text] [Related]
4. Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase.
Mannesse CK; van Puijenbroek EP; Jansen PA; van Marum RJ; Souverein PC; Egberts TC
Drug Saf; 2010 Jul; 33(7):569-78. PubMed ID: 20553058
[TBL] [Abstract][Full Text] [Related]
5. Serotonin syndrome: A pharmacovigilance comparative study of drugs affecting serotonin levels.
Elli C; Novella A; Pasina L
Eur J Clin Pharmacol; 2024 Feb; 80(2):231-237. PubMed ID: 38032391
[TBL] [Abstract][Full Text] [Related]
6. Can tramadol really induce hyponatraemia? A pharmacovigilance study.
de Canecaude C; Rousseau V; Chebane L; Lafaurie M; Durrieu G; Montastruc JL
Br J Clin Pharmacol; 2021 Feb; 87(2):683-686. PubMed ID: 32470196
[TBL] [Abstract][Full Text] [Related]
7. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) or hyponatraemia associated with valproic Acid: four case reports from the Netherlands and a case/non-case analysis of vigibase.
Beers E; van Puijenbroek EP; Bartelink IH; van der Linden CM; Jansen PA
Drug Saf; 2010 Jan; 33(1):47-55. PubMed ID: 20000866
[TBL] [Abstract][Full Text] [Related]
8. Novel adverse events of vortioxetine: A disproportionality analysis in USFDA adverse event reporting system database.
Subeesh V; Singh H; Maheswari E; Beulah E
Asian J Psychiatr; 2017 Dec; 30():152-156. PubMed ID: 28942181
[TBL] [Abstract][Full Text] [Related]
9. Hyponatremia Following Antipsychotic Treatment: In Silico Pharmacodynamics Analysis of Spontaneous Reports From the US Food and Drug Administration Adverse Event Reporting System Database and an Updated Systematic Review.
Mazhar F; Battini V; Pozzi M; Invernizzi E; Mosini G; Gringeri M; Capuano A; Scavone C; Radice S; Clementi E; Carnovale C
Int J Neuropsychopharmacol; 2021 Jul; 24(6):477-489. PubMed ID: 33575781
[TBL] [Abstract][Full Text] [Related]
10. A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Patel NM; Stottlemyer BA; Gray MP; Boyce RD; Kane-Gill SL
Cardiovasc Drugs Ther; 2022 Apr; 36(2):309-322. PubMed ID: 33599896
[TBL] [Abstract][Full Text] [Related]
11. Association between antidepressant drug use and hyponatraemia: a case-control study.
Movig KL; Leufkens HG; Lenderink AW; van den Akker VG; Hodiamont PP; Goldschmidt HM; Egberts AC
Br J Clin Pharmacol; 2002 Apr; 53(4):363-9. PubMed ID: 11966666
[TBL] [Abstract][Full Text] [Related]
12. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
Welch HK; Kellum JA; Kane-Gill SL
Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
[TBL] [Abstract][Full Text] [Related]
13. Identifying Antidepressants Less Likely to Cause Hyponatremia: Triangulation of Retrospective Cohort, Disproportionality, and Pharmacodynamic Studies.
Nagashima T; Hayakawa T; Akimoto H; Minagawa K; Takahashi Y; Asai S
Clin Pharmacol Ther; 2022 Jun; 111(6):1258-1267. PubMed ID: 35258103
[TBL] [Abstract][Full Text] [Related]
14. Serotonergic antidepressants associated with an increased risk for hyponatraemia in the elderly.
Movig KL; Leufkens HG; Lenderink AW; Egberts AC
Eur J Clin Pharmacol; 2002 May; 58(2):143-8. PubMed ID: 12012148
[TBL] [Abstract][Full Text] [Related]
15. Use of Disproportionality Analysis to Identify Previously Unknown Drug-Associated Causes of Cardiac Arrhythmias Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Moreland-Head LN; Coons JC; Seybert AL; Gray MP; Kane-Gill SL
J Cardiovasc Pharmacol Ther; 2021 Jul; 26(4):341-348. PubMed ID: 33403858
[TBL] [Abstract][Full Text] [Related]
16. Detecting a potential safety signal of antidepressants and type 2 diabetes: a pharmacovigilance-pharmacodynamic study.
Siafis S; Papazisis G
Br J Clin Pharmacol; 2018 Oct; 84(10):2405-2414. PubMed ID: 29953643
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 2021.
Jiang T; Su H; Xu J; Li C; Zhang N; Li Y; Wu Y; Ni R; Ming Y; Li Z; Li L; Liu Y
Ther Adv Drug Saf; 2024; 15():20420986231224227. PubMed ID: 38293566
[TBL] [Abstract][Full Text] [Related]
18. Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database.
Revet A; Montastruc F; Roussin A; Raynaud JP; Lapeyre-Mestre M; Nguyen TTH
BMC Psychiatry; 2020 Jun; 20(1):308. PubMed ID: 32546134
[TBL] [Abstract][Full Text] [Related]
19. DPP-4 Inhibitors and Increased Reporting Odds of Bullous Pemphigoid: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) from 2006 to 2020.
Jedlowski PM; Jedlowski MF; Fazel MT
Am J Clin Dermatol; 2021 Nov; 22(6):891-900. PubMed ID: 34287770
[TBL] [Abstract][Full Text] [Related]
20. Hyponatraemia: an audit of aged psychiatry patients taking SSRIs and SNRIs.
Giorlando F; Teister J; Dodd S; Udina M; Berk M
Curr Drug Saf; 2013 Jul; 8(3):175-80. PubMed ID: 23841535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
